Latest research
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Top papers this month · This week's roundup
Trending topics
Meta-analysis of 12 retrospective cohorts (1,247,325 people): metformin use was not associated with glaucoma risk in crude pooled analysis (OR 0.96), though time-to-event analyses from 4 studies suggested modestly lower risk (adjusted HR 0.88; moderate certainty).
Meta-analysisn = 1,247,325
Abdelaal et al. Metformin Use and Risk of Glaucoma: A Systematic Review and Meta-AnalysisUpdate of a meta-analysis on molar-incisor hypomineralisation (MIH), adding one overlooked study (now 139 studies, 199,999 participants): North American prevalence fell slightly from 0.239 to 0.223; global prevalence stayed at 0.155.
Meta-analysisn = 199,999
Ammar et al. Epidemiological trends in enamel hypomineralisation and molar-incisor hypomineralisation: a systematic review and meta-analysisMeta-analysis of 35 studies (n=159,000 adults with confirmed SARS-CoV-2): pooled post-COVID symptom prevalence was 28.5%, higher in pre-Omicron than Omicron eras (35.5% vs 22.8%); symptoms persisted beyond 6 months in 29.9%, with fatigue most common.
Meta-analysisn = 159,000
Lugtu et al. Prevalence of post-COVID symptoms across variants of concern and follow-up periods: A systematic review and meta-analysisMeta-analysis of 22 studies (70,346 patients) after laparoscopic gynaecological surgery: pooled port-site hernia incidence was 0.29%, with high heterogeneity. Higher BMI, diabetes, older age, trocars ≥10 mm, single-port access and poor fascial closure were linked to risk.
Meta-analysisn = 70,346
Ługowski et al. Port-site hernia following laparoscopic gynecological surgery: A systematic review and meta-analysisSystematic review of 27 studies (36,822 patients) after EVAR: aneurysm sac regression was associated with better overall survival than failure to regress (HR 0.70, 95% CI 0.61-0.80); not significant in the fenestrated/branched EVAR subgroup.
Meta-analysisn = 36,822
Çetinel et al. To regress or not to regress? Outcomes of aneurysm sac behavior after endovascular aortic aneurysm repair: A systematic review and meta-analysisIn 29,514 patients at 24 Chinese hospitals, AI-assisted upper endoscopy did not significantly improve gastric neoplasm detection after pathological review vs unassisted (1.42% vs 1.25%; RR 1.13; P=.25), though it reduced blind spots and lengthened procedures.
RCTn = 29,514
Dong et al. Effect of a Computer-Aided Device for Detecting Gastric Neoplasms: A Multicenter, Randomized Controlled TrialSystematic review of 18 studies (27 891 NCAA athletes): 0.24% had a serious cardiovascular condition. In 8 studies (16 609 athletes), ECG found 3.5-fold more true positives than history and exam alone (NNS 475 vs 1661), with fewer false positives (5% vs 17%).
Meta-analysisn = 27,891
Conway et al. Pre-participation cardiovascular screening among NCAA athletes: a systematic review and meta-analysis of 27 891 athletesMeta-analysis of 11 studies (25,659 asymptomatic adults; 13,672 had terminal ileal intubation) at screening or surveillance colonoscopy: pooled yield was 1.74% for any ileal finding, 0.28% for clinically significant pathology and 0.1% for Crohn's disease.
Meta-analysisn = 25,659
Scalvini et al. Diagnostic yield and usefulness of terminal ileal intubation in asymptomatic patients undergoing colonoscopy for colorectal cancer screening or postpolypectomy surveillance: a systematic review and meta-analysisSystematic review of 60 RCTs (22,654 participants) of interventions started within 1 month of self-harm: no category significantly reduced repeat self-harm; problem-solving therapy (OR 0.45) and brief contact (OR 0.34) were associated with fewer suicide deaths.
Meta-analysisn = 22,654
Roncete et al. Acute-Phase Interventions After Self-Harm for Preventing Suicide and Recurrence: A Systematic Review and Meta-AnalysisModelling study applying SELECT trial risk factor changes to 21,720 survey participants with BMI 27 or more and SCORE2 risk 7.5% or more without CVD: emulated GLP-1RA therapy lowered projected 10-year CVD incidence from 13.82% to 10.83%.
RCTn = 21,720
Schrage et al. Emulated Effects of Glucagon-Like Peptide 1 Receptor Agonist Therapy in the General Population